Arkema SA (OTCMKTS:ARKAY – Get Free Report) has been given a consensus rating of “Reduce” by the eight ratings firms that are covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and two have issued a buy recommendation on the company.
Several analysts have recently commented on the stock. Zacks Research cut shares of Arkema from a “hold” rating to a “strong sell” rating in a research note on Tuesday, January 6th. Kepler Capital Markets cut shares of Arkema from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 27th. Deutsche Bank Aktiengesellschaft downgraded Arkema from a “buy” rating to a “hold” rating in a report on Monday, November 24th. Finally, The Goldman Sachs Group upgraded Arkema from a “hold” rating to a “buy” rating in a research report on Tuesday, February 10th.
View Our Latest Report on ARKAY
Arkema Stock Down 1.7%
About Arkema
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Further Reading
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
